Stress Urinary Incontinence:  A Randomized, Evaluator-Blinded, Multi-Center, Study Comparing the Efficacy and Safety of ZUIDEX™ with Contigen® in Female Patients with Stress Urinary Incontinence.

Study Drug: Zuidex™ vs. Contigen®

Primary Objective: To evaluate whether the efficacy of Zuidex™ is at least as good as that of Contigen®.

Study Duration: 12 months

Inclusion Criteria:
1) Female patients aged 18 or older
2) History of stress urinary incontinence for at Least 12 months
3) Patients have failed prior non-invasive treatment such as Kegel exercises, biofeedback.

Exclusion Criteria:
1) Prior treatment with a bulking agent for stress Urinary incontinence.
2) Morbid obesity
3) Patients with predominant urge incontinence
4) Patients with significant pelvic organ prolapse

For more information about the study, please contact the study coordinator at Winter Park Urology Associates: 407-992-2673 or use the form below.

Name:
Address:
City:
State:
Zip Code:
Email:
Phone:
Date of Birth: